可注射的基于生物聚合物的水凝:为最小侵入性疗法提供下一代平台
Nargish Parvin1, Sang Woo Joo1, Tapas Kumar Mandal1,2
1School of Mechanical Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea.
Gels (Basel, Switzerland)
|June 25, 2025
概括
可注射生物聚合物水凝为药物输送和组织修复提供生物相容的解决方案. 本综述涵盖了它们的设计,癌症治疗和再生中的应用以及未来临床翻译挑战.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 再生医学是一种再生医学.
背景情况:
- 可注射生物聚合物基水凝是用于最小侵入性治疗的先进生物材料.
- 它们来自天然的聚合物,如酸盐和原,它们具有生物相容性和生物降解性.
- 这些水凝模仿细胞外基质,增强治疗潜力.
研究的目的:
- 提供最近注射水凝的最新进展的全面概述.
- 突出其设计,交叉连接和生物功能,用于药物输送和组织再生.
- 讨论临床翻译的挑战和未来前景.
主要方法:
- 关于可注射生物聚合物水凝的当前文献的综述.
- 分析水凝设计,交叉连接策略和生物功能性质.
- 检查在向药物输送和各种再生医学领域的应用.
主要成果:
- 可注射水凝在向药物输送和组织再生方面显示出显著的前景.
- 具体应用包括现场凝系统,癌症治疗,肌肉骨修复和神经再生.
- 关键的优势包括模仿细胞外基质,并使微创手术成为可能.
结论:
- 可注射生物聚合物水凝代表了治疗生物材料的重大进步.
- 解决机械强度,降解控制和可扩展制造方面的挑战对于临床成功至关重要.
- 未来的研究应该专注于监管批准和更广泛的临床转化.
更多相关视频
12:22Synthesis of Thermogelling PolyN-isopropylacrylamide-graft-chondroitin Sulfate Composites with Alginate Microparticles for Tissue Engineering
Published on: October 26, 2016
12.0K
09:39Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
Published on: February 7, 2021
8.1K
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
208
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
208
